Related references
Note: Only part of the references are listed.Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
JoAnn E. Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Another Nail in the Coffin for Fish Oil Supplements
Jennifer Abbasi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks Meta-analysis of 10 Trials Involving 77 917 Individuals
Theingi Aung et al.
JAMA CARDIOLOGY (2018)
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association
David S. Siscovick et al.
CIRCULATION (2017)
Effect of Long-Chain ω-3 Fatty Acids and Lutein plus Zeaxanthin Supplements on Cardiovascular Outcomes Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
Denise E. Bonds et al.
JAMA INTERNAL MEDICINE (2014)
n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
Maria Carla Roncaglioni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease A Meta-analysis of Randomized, Double-blind, Placebo-Controlled Trials
Sang Mi Kwak et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Omega 3 Fatty Acids and Cardiovascular Outcomes Systematic Review and Meta-Analysis
Sradha Kotwal et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2012)
Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events A Systematic Review and Meta-analysis
Evangelos C. Rizos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Jackie Bosch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies
Jusheng Zheng et al.
PUBLIC HEALTH NUTRITION (2012)
Omega-3 Fatty Acids and Cardiovascular Disease Effects on Risk Factors, Molecular Pathways, and Clinical Events
Dariush Mozaffarian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
Bernhard Rauch et al.
CIRCULATION (2010)
A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk
Gunnar Einvik et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Daan Kromhout et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial
Pilar Galan et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
n-3 fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies:: a systematic review
Chenchen Wang et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
Share Paper
